---
document_datetime: 2023-09-21 18:47:29
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/prialt-epar-all-authorised-presentations_en.pdf
document_name: prialt-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9051104
conversion_datetime: 2025-12-24 09:16:40.69984
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength   | Pharmaceutical Form   | Route of administration   | Packaging    | Content (concentration)   | Package size   |
|-----------------|-----------------|------------|-----------------------|---------------------------|--------------|---------------------------|----------------|
| EU/1/04/302/001 | Prialt          | 100 μ g/ml | Solution for infusion | Intrathecal use           | Vial (Glass) | 1 ml (100 μ g/ml)         | 1 Vial         |
| EU/1/04/302/002 | Prialt          | 100 μ g/ml | Solution for infusion | Intrathecal use           | Vial (Glass) | 2 ml (100 μ g/ml)         | 1 Vial         |
| EU/1/04/302/003 | Prialt          | 100 μ g/ml | Solution for infusion | Intrathecal use           | Vial (Glass) | 5 ml (100 μ g/ml)         | 1 Vial         |
| EU/1/04/302/004 | Prialt          | 25 μ g/ml  | Solution for infusion | Intrathecal use           | Vial (Glass) | 20 ml (25 μ g/ml)         | 1 Vial         |